AFT Pharma licenses Maxigesic IV in Brazil

New Zealand-based AFT Pharmaceuticals (NZX: AFT) has announced the licensing of Maxigesic IV, the intravenous form of its proprietary pain relief medicine, for Brazil.

AFT Pharmaceuticals managing director Dr Hartley Atkinson said: “We are delighted to announce our partnership with Brazil’s Halex Istar, an established hospital injectables focused company. It is the ideal partner for this market, the most significant in Latin America and one of the most important markets globally.”

Tiago Salinas, chief executive of Halex Istar, added: “We are similarly excited to be establishing this partnership with AFT Pharmaceuticals, to be exclusively responsible for distributing its Maxigesic IV [paracetamol with ibuprofen] in Brazil. This helps Halex Istar to further strengthen its commitment to provide, to the Brazilian hospital pharmaceutical sector, innovative products of excellence. The medicine also complements our current multimodal analgesia portfolio”.